Cargando…
Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
The cyclin kinase inhibitor WAF1/CIP1, also termed CDKN1, mediates p53-induced cell cycle arrest in response to DNA damage. This property makes it an attractive tumour-suppressor candidate for a p53-associated tumour-suppressor gene. In order to investigate the role of WAF1/CIP1 in the pathogenesis...
Autores principales: | Koopmann, J., Maintz, D., Schild, S., Schramm, J., Louis, D. N., Wiestler, O. D., von Deimling, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033923/ https://www.ncbi.nlm.nih.gov/pubmed/7577473 |
Ejemplares similares
-
Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
por: Slebos, R. J., et al.
Publicado: (1996) -
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Lack of Evidence of Association of p21(WAF1/CIP1) Polymorphism with Lung Cancer Susceptibility and Prognosis in Taiwan
por: Shih, Chuen‐Ming, et al.
Publicado: (2000) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004)